Peng et al.[1] reported that the MDR‐TB burden among the new tuberculosis (TB) patients accounted for more than 1/4th of all multidrug‐resistant TB (MDR‐TB) cases in the past 5 years… Click to show full abstract
Peng et al.[1] reported that the MDR‐TB burden among the new tuberculosis (TB) patients accounted for more than 1/4th of all multidrug‐resistant TB (MDR‐TB) cases in the past 5 years in Zhejiang province, although the identified rate of MDR‐TB among 9830 new TB cases was only 2.0%. Drug‐resistant TB, especially MDR‐TB, is a major threat to the control of TB worldwide. However, due to high cost and limited budget, screening on MDR‐TB has not been implemented among all TB cases by now.
               
Click one of the above tabs to view related content.